Journals / Erciyes Tıp Dergisi / 2007 / Cilt: 29 - Sayı: 2

Iatrogenic Cushing’s syndrome due to topical steroid

Topikal steroid kullanımına bağlı iyatrojenik Cushing sendromu

Pages
155–158
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In addition, these findings show that the use of topical steroids, especially during infancy, should be limited to a short period and less potent agents should be preferred

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Iatrogenic Cushing's syndrome due to the use of steroid medication is extremely common because of the widespread use of these medicines in the treatment of many diseases.
📊
Key Findings & Data:Systemic absorption of topical glucocorticoids may result in hypothalamic-pituitary-adrenal axis dysfunction in children.
💡
Conclusion & Impact:In addition, these findings show that the use of topical steroids, especially during infancy, should be limited to a short period and less potent agents should be preferred
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Iatrogenic Cushing's syndrome due to the use of steroid medication is extremely common because of the widespread use of these medicines in the treatment of many diseases. Systemic absorption of topical glucocorticoids may result in hypothalamic-pituitary-adrenal axis dysfunction in children. In this study, two cases with Cushing stigmata were presented. They had been administered topical corticosteroid treatment because of diaper dermatitis. We suggest that physicians should be alert to the signs of Cushing’s syndrome in patients on topical steroid therapy. In addition, these findings show that the use of topical steroids, especially during infancy, should be limited to a short period and less potent agents should be preferred

Özet

Steroid preparatlarının, birçok hastalığın tedavisinde yaygın olarak kullanılmasından kaynaklanan iatrogenik Cushing sendromu son derece sıktır. Topikal glukokortikoidlerin sistemik emilimi, çocuklarda hipotalamo-pituiter-adrenal aksın baskılanmasına neden olabilir. Burada, Cushingoid görünümlü iki olgu sunuldu. Olgulara, diaper dermatit nedeniyle topikal steroid tedavisi verilmişti. Bulgularımız topikal steroid kullanılan hastalarda iyatrojenik Cushing sendromu gelişmesi riskinin olduğunu ve özellikle süt çocukluğu döneminde, topikal steroid kullanımının kısa süre ve düşük potensli ajanlarla sınırlandırılması gerektiğini gösterir

🔖

Cite This Article

HATİPOĞLU, N., KESKİN, M., KURTOĞLU, S., KENDİRCİ, M. (2022). Iatrogenic Cushing’s syndrome due to topical steroid. Erciyes Tıp Dergisi, Cilt: 29 - Sayı: 2, 155–158. https://ajindex.com/articles/502727

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Siklar Z, Bostanci I, Atli O, Dallar Y. An infantile cushing syndrome due to misuse of topical steroid. Pediat Dermatol 2004; 21: 561-563
  2. Gold-von Simson G, Kohn B, Axelrod FB. Cushing syndrome from topical foam steroid use in an adolescent male. Clin Pediatr 2006; 45: 97-100
  3. Allen DB. Safety of inhale corticosteroids in children. Pediatr Pulmonol 2002; 33: 208-220
  4. Perry RJ, Findlay CA, Donaldson MD. Cushing�s syndrome,growth impairment, and occult adrenal supression associated with intranasal steroids. Arch Dis Child 2002; 87: 45-48
  5. Teelucksingh S, Balkaran B, Ganeshmoorthi A, Arthur P.Prolonged childhood Cushing�s syndrome secondray to intralesional triamcinolone acetonide. Ann Trop Paediatr 2002;22: 89-91
  6. Ozerdem U, Levi L, Cheng L, Song MK, Scher C, Freeman WR. Systemic toxicity of topical and periocular corticosteroid therapy in an 11-year-old male with posterior uveitis. Am J Ophthalmol 2000; 130: 240-241
  7. Kumar S, Singh RJ, Reed AM, Lteif AN. Cushing�s Syndrome after intra-articular and intradermal administration of triamcinolone acetonid in three pediatric patients. Pediatrics 2004; 113: 1820-1824
  8. Miller WL. The adrenal cortex and its disorders. In:Brook CGD, Hindmarsh PC, editors. Clinical pediatric endocrinology, 4th edition, Oxford: Blackwell Science, 2001: 356-357
  9. Turpeinen M, Salo O, Leisti S. Effect of percutaneous absorption of hydrocortison on adrenocortical responsiveness in infants with severe skin disease. Br J Dermatol 1986; 115:475-484
  10. Queille C, Pommarede R, Saurat JH. Efficacy versus systemic effect of six topical steroids in the treatment of atopic dermatitis of childhood. Pediatr Dermatol 1984; 1: 246-253
  11. Olsen EA, Cornell R. Topical clobetasol-17-propionate:review of its clinical efficacy and safety. J Am Acad Dermatol 1986; 15: 246-255
  12. Harris DW, Hunter JA. The use and abuse of 0.05 per cent clobetasol propionate in dermatology. Dermatol Clin 1988; 6:643-677
  13. Fritz KA, Weston WL. Topical corticosteroids. Ann Allergy 1983; 50: 68-76
  14. Ohnishi T, Suzuki T, Watanabe S, Takahashi H. Erythrodermic psoriasis associated with hyperuricemia and iatrogenic Cushing's syndrome due to topical corticosteroid therapy. Int J Dermatol 1996; 35: 379-380
  15. Oelkers W. Clinical diagnosis of hyper- and hypocortisolism.Noise Health 2000; 2: 39-48
  16. Nieman LK. Dynamic evaluation of adrenal hypofunction.J Endocrinol Invest 2003; 26: 74-82
  17. Chamberlin P, Meyer WJ. Management of pituiary-adr